[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review

July 2021 | 22 pages | ID: U591585A9F9EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Urigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and commercializes therapeutic products for urological disorders. The company focuses on development of products for symptoms associated with urological ailments and painful bladder syndrome (PBS). Its pipeline products include URG101 and URG501, intended for the treatment of interstitial cystitis and bladder pain syndrome. It also focuses on the development of URG 801, which is in discovery stage, a treatment for Hunner’s lesions of severe interstitial cystitis and bladder pain syndrome. Urigen is headquartered in Bound Brook, New Jersey, the US.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Urigen Pharmaceuticals Inc - Key Facts
Urigen Pharmaceuticals Inc - Key Employees
Urigen Pharmaceuticals Inc - Key Employee Biographies
Urigen Pharmaceuticals Inc - Major Products and Services
Urigen Pharmaceuticals Inc - History
Urigen Pharmaceuticals Inc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Urigen Pharmaceuticals Inc - Business Description
Urigen Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Urigen Pharmaceuticals Inc - Strengths
Urigen Pharmaceuticals Inc - Weaknesses
Urigen Pharmaceuticals Inc - Opportunities
Urigen Pharmaceuticals Inc - Threats
Urigen Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Urigen Pharmaceuticals Inc, Recent Deals Summary

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Urigen Pharmaceuticals Inc, Key Facts
Urigen Pharmaceuticals Inc, Key Employees
Urigen Pharmaceuticals Inc, Key Employee Biographies
Urigen Pharmaceuticals Inc, Major Products and Services
Urigen Pharmaceuticals Inc, History
Urigen Pharmaceuticals Inc, Key Competitors
Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Urigen Pharmaceuticals Inc, Recent Deals Summary

LIST OF FIGURES

Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications